ADMA


Maxim Analyst Downgrades ADMA Biologics Inc (ADMA)

Analyst Jason Kolbert from Maxim Group downgraded ADMA Biologics Inc (NASDAQ:ADMA) to a Hold rating after the company received a CRL from the …